The latest market report published by Credence Research, Inc. "Global Vial Adaptors for Reconstitution Drug Market: Growth, Prospects, and Competitive Analysis, 2016 – 2030". The global vial adaptors for reconstitution drug market generated revenue of around USD 946.8 million in 2022 and is anticipated to grow a CAGR of over 6.50% during the forecast period from 2017 to 2030 to reach around USD 1471.31 million in 2030.
Vial adaptors safely transfer and reconstitute drugs between vials and syringes. They can also be used as a scientific resource in the form of sample vessels, for instance, within autosampler devices within various analytical chromatography procedures. The primary driver for the global vial adaptors for reconstitution drug market is their valuable properties, including heat resistance, impact resistance, ignition resistance, and design flexibility. Additionally, the rising prevalence of chronic disorders and the increasing geriatric population are expected to increase the global market's footprint sustainably.
The global vial adaptors for reconstitution drug market are bifurcated into Product Type, Material, Therapeutic Area, Delivery Mode, and Geography. Based on product type, the market is categorized into 13mm vial adaptor and 20mm vial adaptor. Based on material, the global market is segmented into polycarbonate, silicon, polyethylene teraphthalate glycol, polyethylene, and others. Based on therapeutic area, the market can be split into infectious diseases, autoimmune diseases, metabolic conditions, reproductive health, and others. Based on delivery mode, the market can be categorized into injection and infusion. Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
In 2021, North America occupied the largest vial adaptors for reconstitution drug market share during the forecast period. Factors such as a large presence of key manufacturers and service providers in the region and a favorable government initiative will support widened market growth during the forecast period. Additionally, increasing research participants and a well-developed healthcare infrastructure will increase the market's footprint in the region. The United States is the largest contributor to the North American region owing to the increasing geriatric population.
The Vial Adaptors for Reconstitution Drug Market is expected to witness significant growth in the coming years. This market is driven by a number of factors, including the increasing prevalence of chronic diseases, the growing aging population, and the expanding global market for pharmaceuticals.
In addition, the rising demand for novel drug delivery methods and the need for improved patient compliance are also key drivers of market growth. However, the high cost of vial adaptors and the lack of awareness among clinicians about their use are some of the major challenges faced by this market.
Why to Buy This Report-
- The report provides a qualitative and quantitative analysis of the global vial adaptors for reconstitution drug by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2017-2021, base year- 2022, and forecast period 2017-2030.
- The report contains information related to the competitive landscape, like how the key players in the market are operating at a global, regional, and country level.
- In-depth analysis of the global Vial Adaptors for Reconstitution Drug segmentation based on product type, material, therapeutic areas, delivery mode, and regional integration.
- The global vial adaptors for reconstitution drug report also includes analyzing the global, regional, and country levels, key market trends, significant players analysis, market growth strategies, and key application areas.